Reprogramming by drug-like molecules leads to regeneration of cochlear hair cell-like cells in adult mice
- PMID: 37068229
- PMCID: PMC10151514
- DOI: 10.1073/pnas.2215253120
Reprogramming by drug-like molecules leads to regeneration of cochlear hair cell-like cells in adult mice
Abstract
Strategies to overcome irreversible cochlear hair cell (HC) damage and loss in mammals are of vital importance to hearing recovery in patients with permanent hearing loss. In mature mammalian cochlea, co-activation of Myc and Notch1 reprograms supporting cells (SC) and promotes HC regeneration. Understanding of the underlying mechanisms may aid the development of a clinically relevant approach to achieve HC regeneration in the nontransgenic mature cochlea. By single-cell RNAseq, we show that MYC/NICD "rejuvenates" the adult mouse cochlea by activating multiple pathways including Wnt and cyclase activator of cyclic AMP (cAMP), whose blockade suppresses HC-like cell regeneration despite Myc/Notch activation. We screened and identified a combination (the cocktail) of drug-like molecules composing of small molecules and small interfering RNAs to activate the pathways of Myc, Notch1, Wnt and cAMP. We show that the cocktail effectively replaces Myc and Notch1 transgenes and reprograms fully mature wild-type (WT) SCs for HC-like cells regeneration in vitro. Finally, we demonstrate the cocktail is capable of reprogramming adult cochlea for HC-like cells regeneration in WT mice with HC loss in vivo. Our study identifies a strategy by a clinically relevant approach to reprogram mature inner ear for HC-like cells regeneration, laying the foundation for hearing restoration by HC regeneration.
Keywords: RNAseq; adult mouse cochlea; hair cell regeneration; reprogramming; small moleules and siRNA.
Conflict of interest statement
The authors have organizational affiliations to disclose, Z.-Y.C. is a co-founder and a SAB member of Salubritas Therapeutics, which is developing treatments for hearing loss including genome editing, inner ear regeneration, novel delivery, and gene therapy. Z.-Y.C. has ownership of over 5% equity of Salubritas Therapeutics. Y.-Z.Q. and Z.-Y.C. are co-inventors on a patent application that has been filed based on the study by MEE. A patent application on the combination of small molecules/siRNAs in hair cell regeneration has been filed.
Figures
References
-
- Corwin J. T., Cotanche D. A., Regeneration of sensory hair cells after acoustic trauma. Science 240, 1772–1774 (1988). - PubMed
-
- Ryals B. M., Rubel E. W., Hair cell regeneration after acoustic trauma in adult Coturnix quail. Science 240, 1774–1776 (1988). - PubMed
-
- Hudspeth A. J., How hearing happens. Neuron 19, 947–950 (1997). - PubMed
-
- Warchol M. E., Lambert P. R., Goldstein B. J., Forge A., Corwin J. T., Regenerative proliferation in inner ear sensory epithelia from adult guinea pigs and humans. Science 259, 1619–1622 (1993). - PubMed
-
- Forge A., Li L., Corwin J. T., Nevill G., Ultrastructural evidence for hair cell regeneration in the mammalian inner ear. Science 259, 1616–1619 (1993). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
